January 14, 2021
No sense plus nonsense does not equal common sense
For years we have been extolling the virtues of Tyler. Thanks to advanced insulin delivery technology, either a connected insulin pen or insulin pen cap cover, CGM and insulin dosing algorithms patients following multiple daily injection (MDI) therapy can achieve insulin pump like outcomes at a fraction of the cost of an insulin pump. As we have stated many times Tyler is the single largest threat to the insulin pump market but congruently can also be used as tool to transition MDI patients to a pump. Hence the reason Medtronic acquired Companion Medical.
It’s also known that you can . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
